Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2018-09-20 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MANOSQUE (04100), Alpes-de-Haute-Provence
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DU SOUBEYRAN : revenue, balance sheet and financial ratios
SELAS PHARMACIE DU SOUBEYRAN is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MANOSQUE (04100),
this company of category PME
shows in 2025 a net income positive of 122 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DU SOUBEYRAN (SIREN 842476210)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
121 854 €
147 410 €
117 044 €
228 682 €
273 755 €
170 845 €
59 718 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE DU SOUBEYRAN generates positive net income of 122 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 60 k€ -> 122 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
121 854 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 68%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
67.659%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
53.645%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DU SOUBEYRAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
966.517
351.62
208.44
160.944
138.324
88.362
67.659
Financial autonomy
8.514
19.67
28.076
35.2
38.115
48.01
53.645
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
67.662025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-12 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE DU SOUBEYRAN (67.66) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
53.65%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+13 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE DU SOUBEYRAN (53.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 226.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
226.127
Liquidity indicators evolution SELAS PHARMACIE DU SOUBEYRAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
229.639
256.728
263.85
383.531
303.51
272.833
226.127
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
226.132025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good-11 pts over 3 years
In 2025, the liquidity ratio of SELAS PHARMACIE DU SOUBEYRAN (226.13) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE DU SOUBEYRAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE DU SOUBEYRAN is estimated at
1 935 665 €
(range 1 313 551€ - 3 037 325€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1313k€1935k€3037k€
1 935 665 €Range: 1 313 551€ - 3 037 325€
NAF 5 année 2025
Valuation method used
Net Income Multiple
121 854 €
×
15.9x
=1 935 665 €
Range: 1 313 552€ - 3 037 325€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DU SOUBEYRAN with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DU SOUBEYRAN
What is the revenue of SELAS PHARMACIE DU SOUBEYRAN ?
The revenue of SELAS PHARMACIE DU SOUBEYRAN is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DU SOUBEYRAN profitable?
Yes, SELAS PHARMACIE DU SOUBEYRAN generated a net profit of 122 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE DU SOUBEYRAN ?
The headquarters of SELAS PHARMACIE DU SOUBEYRAN is located in MANOSQUE (04100), in the department Alpes-de-Haute-Provence.
Where to find the tax return of SELAS PHARMACIE DU SOUBEYRAN ?
The tax return of SELAS PHARMACIE DU SOUBEYRAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DU SOUBEYRAN operate?
SELAS PHARMACIE DU SOUBEYRAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart